The single cell RNA sequencing technology is developed to detect genome, transcriptome and other multi-omics of single cells. It has an advantage of analyzing single cells comprehensively that has created unprecedented opportunities for resolving the cell heterogeneity by expanding gene expression. Further, the commercial availability of next generation sequencing and increased focus on single cell analysis along with the maturing bioinformatics approaches has allowed researchers to incorporate the technology in making discoveries. The dramatic improvement within the technology has allowed it for a better usage in embryonic development, cancer biology, and immunology research. The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound annual growth rate (CAGR) of 17.08% during the forecast period 2021–2031. Global Single Cell RNA Sequencing Market Segme...